{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T21:39:28Z","timestamp":1790026768390,"version":"4.0.1"},"reference-count":50,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2017,11,20]],"date-time":"2017-11-20T00:00:00Z","timestamp":1511136000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Int J Dermatology"],"published-print":{"date-parts":[[2018,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>A variety of laser\/light\u2010based devices have been reported to be effective for the treatment of acne, yet no long\u2010term data on efficacy and safety have been published. A first 12\u2010week clinical trial (\u201cMain trial\u201d) recently demonstrated that the <jats:styled-content style=\"fixed-case\">KLOX<\/jats:styled-content> BioPhotonic System, an <jats:styled-content style=\"fixed-case\">LED<\/jats:styled-content> blue light device using photo\u2010converter chromophores, can significantly improve moderate and severe facial acne vulgaris with an excellent safety profile. This Extension trial followed the Main trial, using the same BioPhotonic System, with the same dose and instructions for use, on patients having already completed treatment in the Main trial. Main objectives of this open\u2010label long\u2010term extension 12\u2010week study were to evaluate the efficacy of the <jats:styled-content style=\"fixed-case\">KLOX<\/jats:styled-content> BioPhotonic System on the untreated hemiface during the Main trial, as well as the duration of response on the hemiface treated during the first 12\u2010week Main trial. Despite their young age (mean age: 21.6\u00a0years) and their 12\u2010week participation in the Main trial, 49 (54.4%) of the total number of patients who participated in the Main trial enrolled in this additional 12\u2010week Extension trial. Baseline grading of acne was performed with the Investigator's Global Assessment (<jats:styled-content style=\"fixed-case\">IGA<\/jats:styled-content>) scale. For each patient, the hemiface randomly selected as a control during the Main trial received 6\u00a0weeks of treatment (twice weekly) and was then followed up for an additional 6\u00a0weeks. The first hemiface treated in the Main trial was consequently observed throughout the Extension trial, allowing for a further 12\u2010week assessment of outcomes (total 24\u00a0weeks). In light of an additional 12\u00a0weeks of treatment on the contralateral face, the patient compliance rate was excellent, with 91.9% of the total number of patients receiving at least 80% of the treatments. Patients with a baseline <jats:styled-content style=\"fixed-case\">IGA<\/jats:styled-content> grade of 2 (mild) on the treated hemiface demonstrated a success rate of 58.3 and 66.7% at weeks 6 and 12, respectively. At these same time points, subjects with a baseline <jats:styled-content style=\"fixed-case\">IGA<\/jats:styled-content> grade of 3 (moderate) demonstrated a success rate of 81.8 and 90.0%. Patients with a baseline <jats:styled-content style=\"fixed-case\">IGA<\/jats:styled-content> grade of 4 (severe) demonstrated a success rate of 100% at both week 6 and week 12. When evaluating the originally treated hemifaces from the Main trial, the rate of return to baseline at 24\u00a0weeks was calculated to be 15.5%. This latter outcome confirmed the long duration of effect following treatment. The patient safety profile was also excellent, with very few related adverse events. The BioPhotonic System, which is comprised of <jats:styled-content style=\"fixed-case\">LED<\/jats:styled-content> blue light phototherapy and photo\u2010converter chromophores, provides long\u2010term efficacy and safety in the treatment of acne vulgaris, with a rate of compliance above what is generally observed in a young population of patients suffering from acne vulgaris, especially in light of sequential enrollment in a study treating one hemiface.<\/jats:p>","DOI":"10.1111\/ijd.13814","type":"journal-article","created":{"date-parts":[[2017,11,20]],"date-time":"2017-11-20T09:24:38Z","timestamp":1511169878000},"page":"94-103","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["An extension of a multicenter, randomized, split\u2010face clinical trial evaluating the efficacy and safety of chromophore gel\u2010assisted blue light phototherapy for the treatment of acne"],"prefix":"10.1111","volume":"57","author":[{"given":"Andreas","family":"Nikolis","sequence":"first","affiliation":[{"name":"Division of Plastic Surgery University of Montreal Montreal Qu\u00e9bec Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane","family":"Fauverghe","sequence":"additional","affiliation":[{"name":"KLOX Technologies Inc. Laval Qu\u00e9bec Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Scapagnini","sequence":"additional","affiliation":[{"name":"Department of Medicine and Health Sciences School of Medicine University of Molise Campobasso Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios","family":"Sotiriadis","sequence":"additional","affiliation":[{"name":"Department of Dermatology Aristotle University of Thessaloniki Medical School Papageorgiou General Hospital Thessaloniki Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Kontochristopoulos","sequence":"additional","affiliation":[{"name":"2nd Department of Dermatology Andreas Syggros Hospital Athens Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athanasios","family":"Petridis","sequence":"additional","affiliation":[{"name":"3rd Department of Dermatology Andreas Syggros Hospital Athens Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios","family":"Rigopoulos","sequence":"additional","affiliation":[{"name":"Attikon University General Hospital of Athens University of Athens Athens Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clio","family":"Dessinioti","sequence":"additional","affiliation":[{"name":"1st Department of Dermatology Andreas Syggros Hospital University of Athens Athens Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Kalokasidis","sequence":"additional","affiliation":[{"name":"Department of Dermatology Aristotle University of Thessaloniki Medical School Papageorgiou General Hospital Thessaloniki Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Antoniou","sequence":"additional","affiliation":[{"name":"1st Department of Dermatology Andreas Syggros Hospital University of Athens Athens Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2017,11,20]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-014-0099-z"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200363150-00005"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2015.12.037"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.13634"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)60321-8"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1002\/lsm.22410"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pdpdt.2016.04.005"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.13579"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1159\/000382031"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1574-695X.2003.tb00644.x"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.12186"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-0088"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4725.2004.30053.x"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1562\/0031-8655(2002)0760164BEOPL2.0.CO2"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.4062\/biomolther.2014.083"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.2203\/dose-response.11-009.Hamblin"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2009.09047.x"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0781.2004.00109.x"},{"key":"e_1_2_6_20_1","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/j.1473-2165.2008.00386.x","article-title":"An assessment of the efficacy of blue light phototherapy in the treatment of acne vulgaris","volume":"7","author":"Ammad S","year":"2007","journal-title":"J\u00a0Cosmet Dermatol"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.291.23.2834"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1080\/14764170600735912"},{"key":"e_1_2_6_23_1","first-page":"676","article-title":"Treatment of facial acne papules and pustules in Korean patients using a device equipped with a 530\u2010 to 750\u2010nm filter","volume":"33","author":"Chang SE","year":"2007","journal-title":"Dermatol Surg"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2009.03525.x"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4632.2011.05295.x"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1111\/ced.12010"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.3109\/14764172.2013.864198"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2009.186"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2010.09806.x"},{"key":"e_1_2_6_30_1","first-page":"77","article-title":"Efficacy of red light alone and methyl\u2010aminolevulinate photodynamic therapy for the treatment of mild and moderate facial acne","volume":"19","author":"Pinto C","year":"2013","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"e_1_2_6_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2014.05.047"},{"key":"e_1_2_6_32_1","first-page":"395","article-title":"Prospective randomized controlled clinical and histopathological study on acne vulgaris treated with dual mode of quasi\u2010long pulse and Q\u2010switched 1064\u2010nm Nd: YAG laser assisted with a topically applied carbon suspension","volume":"163","author":"Jung JY","year":"2010","journal-title":"J Am Acad Dermatol"},{"key":"e_1_2_6_33_1","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2013.1455"},{"key":"e_1_2_6_34_1","doi-asserted-by":"publisher","DOI":"10.1097\/DSS.0000000000000167"},{"key":"e_1_2_6_35_1","doi-asserted-by":"publisher","DOI":"10.1111\/phpp.12031"},{"key":"e_1_2_6_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.det.2015.11.003"},{"key":"e_1_2_6_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.rser.2010.02.015"},{"key":"e_1_2_6_38_1","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.13349"},{"key":"e_1_2_6_39_1","doi-asserted-by":"publisher","DOI":"10.1002\/lsm.22219"},{"key":"e_1_2_6_40_1","doi-asserted-by":"publisher","DOI":"10.1002\/lsm.20107"},{"key":"e_1_2_6_41_1","doi-asserted-by":"publisher","DOI":"10.1002\/lsm.20533"},{"key":"e_1_2_6_42_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1440-172x.2002.00338.x"},{"key":"e_1_2_6_43_1","unstructured":"U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER).Guidance for Industry; Acne Vulgaris: Developing Drugs for Treatment (Draft Guidance) 2005;1\u201314. Available at:http:\/\/www.fda.gov\/downloads\/Drugs\/GuidanceComplianceRegulatoryInformation\/Guidances\/UCM071292.pdf."},{"key":"e_1_2_6_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2007.06.045"},{"key":"e_1_2_6_45_1","doi-asserted-by":"publisher","DOI":"10.1159\/000107624"},{"key":"e_1_2_6_46_1","doi-asserted-by":"publisher","DOI":"10.3109\/14764172.2014.988727"},{"key":"e_1_2_6_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2012.07.001"},{"key":"e_1_2_6_48_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.12186"},{"key":"e_1_2_6_49_1","doi-asserted-by":"publisher","DOI":"10.1080\/09546630500283664"},{"key":"e_1_2_6_50_1","doi-asserted-by":"publisher","DOI":"10.3109\/14764172.2015.1007064"},{"key":"e_1_2_6_51_1","doi-asserted-by":"publisher","DOI":"10.1111\/phpp.12098"}],"container-title":["International Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fijd.13814","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ijd.13814","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,29]],"date-time":"2023-09-29T22:49:06Z","timestamp":1696027746000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/ijd.13814"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,20]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["10.1111\/ijd.13814"],"URL":"https:\/\/doi.org\/10.1111\/ijd.13814","archive":["Portico"],"relation":{},"ISSN":["0011-9059","1365-4632"],"issn-type":[{"value":"0011-9059","type":"print"},{"value":"1365-4632","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,20]]},"assertion":[{"value":"2016-12-21","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-09-21","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-11-20","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}